These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Surgery with adjuvant irradiation in patients with pathologic stage C adenocarcinoma of the prostate. Petrovich Z; Lieskovsky G; Freeman J; Luxton G; Groshen S; Formenti S; Baert L; Chen SC; Skinner DG Cancer; 1995 Nov; 76(9):1621-8. PubMed ID: 8635067 [TBL] [Abstract][Full Text] [Related]
4. Results of radical prostatectomy and adjuvant therapy in the management of locally advanced, clinical stage TC, prostate cancer. Yamada AH; Lieskovsky G; Petrovich Z; Chen SC; Groshen S; Skinner DG Am J Clin Oncol; 1994 Aug; 17(4):277-85. PubMed ID: 8048388 [TBL] [Abstract][Full Text] [Related]
5. Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins: therapeutic implications. Han M; Pound CR; Potter SR; Partin AW; Epstein JI; Walsh PC J Urol; 2001 Mar; 165(3):864-6. PubMed ID: 11176487 [TBL] [Abstract][Full Text] [Related]
6. Results of local and/or systemic adjuvant therapy in the management of pathological stage C or D1 prostate cancer following radical prostatectomy. Carter GE; Lieskovsky G; Skinner DG; Petrovich Z J Urol; 1989 Nov; 142(5):1266-70; discussion 1270-1. PubMed ID: 2810504 [TBL] [Abstract][Full Text] [Related]
7. Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression. Zincke H; Utz DC; Taylor WF J Urol; 1986 Jun; 135(6):1199-205. PubMed ID: 3086572 [TBL] [Abstract][Full Text] [Related]
8. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for Stage C adenocarcinoma of prostate. Zincke H; Utz DC; Benson RC; Patterson DE Urology; 1984 Dec; 24(6):532-9. PubMed ID: 6506391 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiation therapy in patients upstaged to stage C or D1 disease after radical prostatectomy. Sidi AA; Lange PH Eur Urol; 1987; 13(4):238-41. PubMed ID: 3653164 [TBL] [Abstract][Full Text] [Related]
11. Radical prostatectomy and adjuvant radioactive gold seed placement: results of treatment at 5 and 10 years for clinical stages A2, B1 and B2 cancer of the prostate. Kwon ED; Loening SA; Hawtrey CE J Urol; 1991 Mar; 145(3):524-31. PubMed ID: 1997703 [TBL] [Abstract][Full Text] [Related]
12. Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987. Steinberg GD; Epstein JI; Piantadosi S; Walsh PC J Urol; 1990 Dec; 144(6):1425-32. PubMed ID: 1700157 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiotherapy in patients with pathologic Stage C (pT3N0) adenocarcinoma of the prostate. Petrovich Z; Lieskovsky G; Langholz B; Bochner B; Formenti S; Streeter O; Skinner DG Urology; 1999 Jun; 53(6):1184-93. PubMed ID: 10367850 [TBL] [Abstract][Full Text] [Related]
14. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. Catalona WJ; Smith DS J Urol; 1998 Dec; 160(6 Pt 2):2428-34. PubMed ID: 9817397 [TBL] [Abstract][Full Text] [Related]
15. Radiation therapy as adjuvant treatment after radical prostatectomy. Lange PH; Reddy PK; Medini E; Levitt S; Fraley EE NCI Monogr; 1988; (7):141-9. PubMed ID: 2459621 [TBL] [Abstract][Full Text] [Related]
16. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342 [TBL] [Abstract][Full Text] [Related]
17. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy. Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480 [TBL] [Abstract][Full Text] [Related]
18. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300 [TBL] [Abstract][Full Text] [Related]
19. Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer. Miyake H; Sakai I; Harada K; Hara I; Eto H Int J Urol; 2004 Jun; 11(6):397-401. PubMed ID: 15157209 [TBL] [Abstract][Full Text] [Related]
20. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. Trapasso JG; deKernion JB; Smith RB; Dorey F J Urol; 1994 Nov; 152(5 Pt 2):1821-5. PubMed ID: 7523728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]